Gene · 5919
NIH grants908
NIH grants whose papers are about the gene, through NIH's grant-paper links.
21 to 40 of 908
Download this page as JSON| Grant | Title | RARRES2 papers | Newest fiscal year |
|---|---|---|---|
| IK6BX005224 | BLR&D Research Career Scientist Award Application | 1 | 2025 |
| K01AG071689 | Integrated multi-omics approach to identify early protein biomarkers in Alzheimer's disease and cognitive decline | 1 | 2025 |
| K12GM068524 | San Diego IRACDA Scholars Program | 1 | 2025 |
| K12GM093857 | Virginia Commonwealth University IRACDA | 1 | 2025 |
| K23DK135414 | Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV | 1 | 2025 |
| K23HL156759 | Anti-cytomegalovirus Immune Responses in Atherosclerotic Cardiovascular Disease in Persons Living with HIV | 1 | 2025 |
| K23HL171855 | Mixed meal tolerance test elicited metabolite responses as novel markers of cardiometabolic risk | 1 | 2025 |
| K24AI157882 | Consequences of Persistent Immune Activation among ART-treated Women with HIV | 1 | 2025 |
| K24AR076975 | Linking Disease Mechanisms and Outcomes in Rheumatic Diseases | 1 | 2025 |
| KL2TR002245 | Institutional Career Development Core | 1 | 2025 |
| KL2TR002367 | Institutional Career Development Core | 1 | 2025 |
| P01AG036695 | Molecular Regulation of Stem Cell Aging | 1 | 2025 |
| P01AG062413 | Targeting Cellular Senescence to Extend Healthspan | 1 | 2025 |
| P01CA163205 | Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas | 1 | 2025 |
| P01CA214091 | Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies | 1 | 2025 |
| P01CA275740 | ExpLoiting thErapeutic VulnerAbilities in hepaTocEllular carcinoma (ELEVATE) | 1 | 2025 |
| P01HL114501 | Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers | 1 | 2025 |
| P20GM103424 | Louisiana Biomedical Research Network | 1 | 2025 |
| P20GM103429 | Partnerships for Biomedical Research in Arkansas | 1 | 2025 |
| P20GM103443 | SD INBRE Administrative Supplement Extension | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5919/grants?page=2